谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial

Helena Marzo-Ortega,Joachim Sieper,Alan J. Kivitz,Ricardo Blanco,Martin Cohen,Karel Pavelka,Eumorphia M. Delicha,Anna Stefanska,Hanno B. Richards,Susanne Rohrer

The Lancet Rheumatology（2020）

引用 34|浏览14
暂无评分
关键词
ankylosing spondylitis,secukinumab,end-of-study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要